New Key Statistics Module, Z-Score and F-Score
LSE:GSK Key Ratios
Market Cap £ M | 57,004.58 |
Enterprise Value £ M | 69,851.58 |
P/E(ttm) | 22.90 |
PE Ratio without NRI | 19.48 |
Forward PE Ratio | 8.26 |
Price/Book | 4.07 |
Price/Sales | 1.84 |
Price/Free Cash Flow | 12.02 |
Price/Owner Earnings | 13.20 |
Payout Ratio % | 0.84 |
Revenue (TTM) £ M | 31,311.00 |
EPS (TTM) £ | 0.61 |
Beneish M-Score | -3.01 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -31.80 |
EV-to-EBIT | 17.71 |
EV-to-EBITDA | 10.42 |
PEG | 19.48 |
Shares Outstanding M | 4,080.50 |
Net Margin (%) | 8.02 |
Operating Margin % | 14.37 |
Pre-tax Margin (%) | 10.52 |
Quick Ratio | 0.53 |
Current Ratio | 0.81 |
ROA % (ttm) | 4.26 |
ROE % (ttm) | 18.28 |
ROIC % (ttm) | 8.01 |
Dividend Yield % | 4.29 |
Altman Z-Score | 1.64 |
LSE:GSK Number of Guru Trades
LSE:GSK Volume of Guru Trades
Gurus Latest Trades with LSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LSE:GSK is held by these investors
Total 1